Versatile capabilities for liquid chromatography in SARS-CoV-2 research

Liquid chromatography is a central tool in research revolving around vaccine and therapeutic development for SARS-CoV-2. KNAUER has more than 55 years experience in liquid chromatography and is a committed partner to help you advance SARS-CoV-2 research. Chromatography is not only limited to one aspect of research. It can be used in multiple ways ranging from analytical tasks to preparative purification and protein purification. Find a selection of KNAUER chromatography products and how they can help to discover, understand and develop treatments against SARS-CoV-2. 

FPLC in SARS-CoV-2 research

Several SARS-CoV-2 proteins present major targets for vaccination and antiviral strategies. Structural data of these proteins gives valuable information for drug and vaccine development. One of the important steps on the way for structural analysis is the purification of proteins in solution. FPLC is the method of choice to support your protein purification task.  

RNA purification to fight SARS-CoV-2

RNA therapeutics are a hot topic in the race for a SARS-CoV-2 vaccine. Tailor made RNA can be used to induce the human body to produce therapeutic proteins by itself, which in turn help the immune system to fight the virus. Purification of the to be used RNA is of great importance to secure high quality of the product and circumvent unwanted side effects.  

We have developed the RNA Purifier, a preparative HPLC system for batch purification of RNA with ternary pump, UV detection and thermal control to support your SARS-CoV-2 research.

Analysis of active agents​

Quality control and extensive analysis of active agents is one of the key steps to release a drug or even start drug testing. Analytical HPLC is a reliable and fast tool for this crucial step. KNAUER has a long history of providing robust, reliable and easy to use systems for all aspects of analytical HPLC. 

Follow us on: